£147.49

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£147 today · all-time low £145 (Sep 2026) · usually £146

Springer Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£149.64 £144.58 £145.68 £146.79 £147.89 £149.00 £150.10 25 July 2026 09 August 2026 24 August 2026 08 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 3 price levels

Days at Price
Current Price
10 days 1 day · current 51 days 0 13 26 38 51 £145 £147 £150 Days at Price

Price Analysis

Most common price: £150 (51 days, 82.3%)

Price range: £145 - £150

Price levels: 3 different prices over 62 days

Description

This volume mainly contains information on the diagnosis, therapy, and prognosis of brain tumors. Insights on the understanding of molecular pathways involved in tumor biology are explained, which should lead to the development of effective drugs. Information on pathways (e.g., hedgehog) facilitates targeted therapies in cancer. Tumor models are also presented, which utilize expression data, pathway sensitivity, and genetic abnormalities, representing targets in cancer. For example, rat model of malignant brain tumors using implantation of doxorubicin with drug eluting beads for delivery is explained. The future of pathway-driven therapies for tumors is summarized. The importance of personalizing cancer care is emphasized. The need for supportive measures for survivors of brain cancer is pointed out, so is the quality of life monitoring. The need of rehabilitation therapy for patients with primary and metastatic brain tumors is also emphasized. Role of MicroRNA in distinguishing primary tumors from metastatic primary tumors is discussed. Advantages and limitations of chemotherapy (e.g., temozolomide and doxorubicin) are discussed. The complexity of tumor to tumor transfer is explained; examples discussed are: brain metastases from breast cancer and brain metastases fro non-small cell lung carcinoma. Identification and characterization of biomarkers, including those for metastatic brain tumors, are presented. Genomic analysis for identifying clinically relevant subtypes of glioblastoma is included. A large number of imaging modalities are detailed to study progression and invasion of gliomas

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
29 November 2013
Listed Since
07 November 2013

Barcode

No barcode data available

Similar Products You Might Like

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
99% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£117.56 15 Aug 2026
Animal Models of Brain Tumors: 77 (Neuromethods, 77)
97% match

Animal Models of Brain Tumors: 77 (Neuromethods, 77)

Humana

£80.67 08 Oct 2026
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)
97% match

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Elsevier

£119.00 23 Sep 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£155.47 27 Sep 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.78 02 Sep 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
97% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.71 02 Sep 2026
Brain Tumors: 158 - Neuromethods Research Models & Techniques
97% match

Brain Tumors: 158 - Neuromethods Research Models & Techniques

Springer

£114.23 04 Oct 2026
Combined Modality Therapy of CNS Tumors - Medical Radiology
97% match

Combined Modality Therapy of CNS Tumors - Medical Radiology

Springer

£124.48 05 Oct 2026
Neuro-Oncology Part II - Handbook Clinical Neurology Vol 105
97% match

Neuro-Oncology Part II - Handbook Clinical Neurology Vol 105

Elsevier

£127.99 02 Oct 2026
Tumors of the Central Nervous System Volume 9 - Springer Medical Reference
97% match

Tumors of the Central Nervous System Volume 9 - Springer Medical Reference

Springer

£107.83 06 Oct 2026
Brain Tumor Pathology: Diagnostic Hotspots and Pitfalls
97% match

Brain Tumor Pathology: Diagnostic Hotspots and Pitfalls

Springer

£82.98 08 Oct 2026
Elsevier Neuro-Oncology Part I: Volume 104 Handbook
97% match

Elsevier Neuro-Oncology Part I: Volume 104 Handbook

Elsevier

£141.79 06 Oct 2026
Molecular Pathology of Nervous System Tumors - Springer Medical Guide
97% match

Molecular Pathology of Nervous System Tumors - Springer Medical Guide

Springer

£99.56 17 Sep 2026
New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics
97% match

New Insights into Glioblastoma: Diagnosis, Therapeutics and Theranostics

Elsevier

£119.37 19 Aug 2026
Brain Tumors: Contemporary Cancer Research - Humana
97% match

Brain Tumors: Contemporary Cancer Research - Humana

Humana

£38.17 04 Oct 2026
Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)
97% match

Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)

Springer

£149.00 02 Oct 2026
New Insights into Functional Mapping in Cerebral Tumor Surgery
97% match

New Insights into Functional Mapping in Cerebral Tumor Surgery

£56.99 23 Sep 2026
High-Grade Gliomas: Diagnosis and Treatment - Current Clinical Oncology
97% match

High-Grade Gliomas: Diagnosis and Treatment - Current Clinical Oncology

Humana

£75.25 13 Sep 2026
Resistance to Targeted Therapies Against Adult Brain Cancers - Springer
97% match

Resistance to Targeted Therapies Against Adult Brain Cancers - Springer

Springer

£129.99 05 Oct 2026
Glioblastoma
97% match

Glioblastoma

Elsevier

£76.40 13 Aug 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
97% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£141.67 19 Aug 2026
Brain Tumor Stem Cells: Methods and Protocols: 1869 (Methods in Molecular Biology, 1869)
97% match

Brain Tumor Stem Cells: Methods and Protocols: 1869 (Methods in Molecular Biology, 1869)

Humana

£107.85 17 Oct 2026
Advances and Technical Standards in Neurosurgery: Volume 43
97% match

Advances and Technical Standards in Neurosurgery: Volume 43

Springer

£79.99 11 Sep 2026
High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)
97% match

High-Grade Gliomas: Diagnosis and Treatment (Current Clinical Oncology)

Humana

£156.70 24 Sep 2026